<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03932214</url>
  </required_header>
  <id_info>
    <org_study_id>PHRIP-18-0617</org_study_id>
    <nct_id>NCT03932214</nct_id>
  </id_info>
  <brief_title>Infrared for Peripheral Venous Catheterization in the Critically-ill</brief_title>
  <acronym>ICARE</acronym>
  <official_title>Infrared Illumination for Difficult Peripheral Venous Catheterization in Adult Critically-ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peripheral venous catheterization is a fundamental part of the management of critically-ill&#xD;
      patients, especially for administration of intravenous emergency treatments. In general, it&#xD;
      is preferred to central catheterization whenever possible, since it is less invasive,&#xD;
      achievable immediately by the nurse, and responsible for fewer complications.&#xD;
&#xD;
      Venous access difficulties are frequent in critically-ill patients. Among tools proposed to&#xD;
      improve the practice of peripheral catheterization, ultrasound and infrared illumination are&#xD;
      the most studied, the latter being simpler. Infrared illumination has never been evaluated in&#xD;
      intensive care. However, the delay or failure of peripheral catheterization is highly&#xD;
      detrimental in the context of resuscitation as it may delay or impede appropriate management&#xD;
      of vital emergencies. Our study will focus on the peripheral venous catheterization of the&#xD;
      upper limbs, as these are the reference site for this technique The objective is to evaluate&#xD;
      the interest of infrared illumination (AccuVein AV500®) for the primary success (first&#xD;
      puncture) of peripheral venous catheterization of the upper limbs in patients with&#xD;
      resuscitation at risk of catheterization venous difficult.&#xD;
&#xD;
      It is a comparative, superiority, prospective, multicenter, randomized, controlled,&#xD;
      open-label, phase III trial. Subjects will be divided into two groups with a 1: 1 ratio.&#xD;
      Nurses at participating centers will be trained for the use of the device prior to the start&#xD;
      of the study; the use of the device is singularly easy and intuitive.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects will be divided into two groups with a 1: 1 ratio. Each patient will be assigned to one of the following 2 arms:&#xD;
- Usual technique : Visualization of the vein to be catheterized will be done directly. without infrared illumination.&#xD;
or&#xD;
-Use of the Accuvein® device: Visualization of the vein to be catheterized will be done with infrared illumination.&#xD;
In both groups, catheterization will be carried out according to the usual technique in accordance with the recommendations.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of primary success of peripheral venous catheterization in the upper limbs.</measure>
    <time_frame>Day 1</time_frame>
    <description>success defined as the need of a single puncture for the effective catheterization.&#xD;
The effective catheterization is confirmed by obtaining venous reflux by declivity of the infusion bag.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of punctures required for peripheral venous catheterization.</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of failure of the procedure, defined by the absence of placement of a peripheral venous catheter before the end of the procedure</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">460</enrollment>
  <condition>Peripheral Venous Catheterization</condition>
  <arm_group>
    <arm_group_label>Infrared illumination group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The nurse uses the Accuvein® device to identify the veins before puncture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The nurse proceeds as usual (visual identification in the light of the room and palpation)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ACCUVEIN</intervention_name>
    <description>The nurse uses the Accuvein® device to identify the veins before puncture and then proceeds as usual, under illumination of the device.</description>
    <arm_group_label>Infrared illumination group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years; Hospitalization in intensive care;&#xD;
&#xD;
          -  Need for a peripheral venous catheter;&#xD;
&#xD;
          -  Risk of difficult peripheral venous catheterization. In practice, this risk will be&#xD;
             considered present if it is impossible to palpate and / or visualize the upper end of&#xD;
             the target vein and / or if the estimated vein diameter is smaller than 2mm. This&#xD;
             definition is derived from the A-DIVA score (Loon FAJ van et al3).&#xD;
&#xD;
          -  Affiliation to the social security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient who has already been enrolled in the ICARE study during the current&#xD;
             hospitalization;&#xD;
&#xD;
          -  Refusal of patient's participation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabien BOUSSELY, senior officer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance publique des hopitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabien BOUSSELY, senior officer</last_name>
    <phone>01 49 81 42 50</phone>
    <phone_ext>33</phone_ext>
    <email>fabien.boussely@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Akim SOUAG</last_name>
    <phone>(0)1 44 84 17 15</phone>
    <phone_ext>33</phone_ext>
    <email>akim.souag@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Henri-Mondor Hospital</name>
      <address>
        <city>Créteil</city>
        <state>Val De Marne</state>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabien Boussely</last_name>
      <email>fabien.boussely@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://www.has-sante.fr/portail/upload/docs/application/pdf/Catheters_veineux_2005_rap.pdf</url>
    <description>Société française d'hygiène hospitalière (SF2H). Prévention des infections liées aux cathéters veineux périphériques. [Internet]. 2005 [cited 2017 Sep 1];</description>
  </link>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S0196064412017490</url>
    <description>Heinrichs J, Fritze Z, Vandermeer B, Klassen T, Curtis S. Ultrasonographically Guided Peripheral Intravenous Cannulation of Children and Adults: A Systematic Review and Meta-analysis - ScienceDirect [Internet]</description>
  </link>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S0196064405000570</url>
    <description>Costantino TG, Parikh AK, Satz WA, Fojtik JP. Ultrasonography-Guided Peripheral Intravenous Access Versus Traditional Approaches in Patients With Difficult Intravenous Access - ScienceDirect [Internet]. [cited 2017 Sep 1]</description>
  </link>
  <reference>
    <citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.</citation>
    <PMID>23353941</PMID>
  </reference>
  <reference>
    <citation>Loon FHJV, Puijn LAPM, Houterman S, Bouwman ARA. Development of the A-DIVA Scale: A Clinical Predictive Scale to Identify Difficult Intravenous Access in Adult Patients Based on Clinical Observations. Medicine (Baltimore). 2016 Apr;95(16):e3428. doi: 10.1097/MD.0000000000003428.</citation>
    <PMID>27100437</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>April 26, 2019</study_first_submitted>
  <study_first_submitted_qc>April 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2019</study_first_posted>
  <last_update_submitted>October 23, 2020</last_update_submitted>
  <last_update_submitted_qc>October 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>venous access</keyword>
  <keyword>illumination, infrared</keyword>
  <keyword>critically-ill</keyword>
  <keyword>catheterization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

